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S U M M A R Y
Background: The diversity of clinical manifestations of leprosy has given rise to different classiﬁcation
systems. However, there are important differences in the sensitivity and speciﬁcity of these
classiﬁcations. The objective of this study was to evaluate the agreement between clinical and
histopathological data for classifying leprosy.
Methods: A total of 1265 patient reports containing clinical and histopathological data relating to the
diagnosis and classiﬁcation of leprosy were included in this study. The diagnostic concordance between
the clinical form (Madrid classiﬁcation) and the histopathological type, as well as the initial and ﬁnal
classiﬁcations, was calculated by dividing the number of concordant cases by the total number of
patients.
Results: The overall agreement between the World Health Organization operational classiﬁcation and
the results of direct smear examination of the lesion for acid-fast bacilli was 84.8% (1073/1265). The
clinical–histopathological agreement was 58.1% (735/1265). The indeterminate and lepromatous forms
were those that showed the highest percentages of agreement: 72.1% (186/258) and 71.0% (142/200),
respectively.
Conclusion: Although classiﬁcations based on clinical characteristics have an important role in the
control of leprosy, they present ﬂaws that can inﬂuence the adequacy of treatment. Therefore, a
histopathological examination is important for appropriate treatment.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Leprosy is a chronic infectious granulomatous disease with a
prolonged incubation period that affects the skin and peripheral
nerves. It is caused by Mycobacterium leprae, which parasitizes
macrophages and Schwann cells.1,2
Annually, approximately 200 000 people are affected through-
out the world. The highest detection rates are found in developing
countries located in Southeast Asia, Africa, and South America. In
2010, Brazil was the country with the second highest number of
cases in the world, only behind India.3
Leprosy has a variety of clinical, microbiological, and patholog-
ical ﬁndings, and it is diagnosed based mainly on the presence of
skin lesions, loss of sensitivity, and neural thickening. The various* Corresponding author.
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cellular immune response to M. leprae,1,2,4 which are expressed
through different pathophysiological mechanisms, with particular
signs, symptoms, progression, prognosis, and contagion that have
allowed numerous classiﬁcations. However, these classiﬁcations
present important differences regarding sensitivity and speciﬁcity,
and thus require critical analysis for their application, especially in
regions that are considered endemic.5,6
The classiﬁcation proposed by Rabello at the International
Leprosy Congress in Madrid in 1953, took into account clinical data
and the characteristics of skin lesions presented by patients by
dividing them into spectral forms: indeterminate (I), tuberculous
(T), dimorphic (D), and lepromatous (L).7,8
In 1966, Ridley and Jopling introduced a classiﬁcation system
based on histopathological ﬁndings and on the level of cellular
immunity.9 From these criteria, leprosy patients were divided into
ﬁve groups: tuberculoid (TT), borderline tuberculoid (BT), mid-
borderline (BB), borderline lepromatous (BL), and lepromatousses. Published by Elsevier Ltd. All rights reserved.
Table 2
Agreement between clinical and histopathological classiﬁcations for patients with
leprosy; PDNPM, 1985–2005
Clinical
classiﬁcationa
Histopathological
classiﬁcationb
Agreement, n (%) Total
I TT BBc LL
I 186 55 11 6 186/258 (72.1%) 258
T 212 375 24 35 375/646 (58.0%) 646
D 36 51 32 42 32/161 (19.9%) 161
L 17 26 15 142 142/200 (71.0%) 200
Total 451 507 82 225 735/1265 (58.1%) 1265
Kappa = 0.371, p = 0.000.
a I, indeterminate; T, tuberculous; D, dimorphic; L, lepromatous.
b I, indeterminate; TT, tuberculoid; BB, mid-borderline; LL, lepromatous.
c BB = includes BT (borderline tuberculoid), BB, and BL (borderline lepromatous).
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any of the ﬁve groups.10
For treatment purposes, the World Health Organization (WHO)
recommends the ‘operational classiﬁcation’, based on the number
of skin lesions and/or affected nerve trunks. This is recommended
because many countries lack the resources required to conduct
good quality direct smear examinations for acid-fast bacilli.
According to this classiﬁcation, leprosy cases are considered
paucibacillary with up to ﬁve skin lesions and/or only one affected
nerve trunk, and are considered multibacillary with over ﬁve skin
lesions and/or more than one affected nerve trunk.11,12 However, if
the direct smear microscopy test is available, patients who present
positive dermal smears will be classiﬁed as multibacillary,
regardless of the number of skin lesions.13–15
A correct classiﬁcation makes it possible to institute appropri-
ate treatment and decreases the transmission of the disease, as
well as the chances of recurrence, physical disability, and
deformity.5,7,8,15,16 Deformities can bring problems like reduced
ability to work and limitations in the person’s social life, and are
responsible for the stigma and prejudice against this disease.13,16
However, studies have shown that difﬁculties in establishing
the correct classiﬁcation exist, and have also demonstrated a lack
of concordance between the clinical and histopathological
classiﬁcations.8,17–19 Furthermore, the simpliﬁed criteria adopted
by the WHO are not predictive of the correct immunohistopatho-
logical classiﬁcation, which raises the need for a clinical diagnosis
accompanied by direct smear microscopy and histopathological
examination of the lesion, especially in endemic regions.7,8,15,20,21
Hence, the aim of the present study was to evaluate the
agreement between the clinical and histopathological data for
classifying leprosy.
2. Materials and methods
This was a descriptive retrospective study, with a quantitative
approach, based on the analysis of skin biopsy reports from
patients presenting clinical and histopathological data concordant
with a diagnosis of leprosy, who attended between January 1985
and December 2005. All the reports are ﬁled at the Prof. Dr. Nestor
Piva Memorial (PDNPM) facility of Tiradentes University (UNIT).
Out of the 2102 reports involving a histopathological diagnosis of
leprosy, 1265 were included in this study because they presented a
full clinical summary that indicated a suspicion of leprosy. The
information contained in these reports was organized using a
speciﬁc questionnaire, and the following were thus identiﬁed:
clinical suspicion relating to the operational classiﬁcation, clinical
suspicion relating to the Madrid classiﬁcation, direct smear
microscopy of the lesion, and histopathological classiﬁcation.
All the information obtained was coded and entered into a
database. An exploratory analysis was conducted on the data,
consisting of calculating simple, absolute, and percentage fre-
quencies for the categorical variables and organizing the results
into tables through descriptive analysis and associations between
variables.Table 1
Agreement between the initial and ﬁnal operational classiﬁcations after direct smear m
Initial operational classiﬁcation Final operational classiﬁcation 
microscopy)
Paucibacillary 
Paucibacillary 866 
Multibacillary 125 
Total 991 
Kappa = 0.584, p = 0.000.The diagnostic concordance between the clinical form (Madrid
classiﬁcation) and the histopathological type, as well as the initial
and ﬁnal classiﬁcations, was calculated by dividing the number
of concordant cases by the total number of patients. The kappa test
was applied to evaluate the concordance results. The kappa values
and their interpretations were as follows: <0, no agreement;
0–0.19, very weak agreement; 0.20–0.39, weak agreement;
0.40–0.59, moderate agreement; 0.60–0.79, substantial agree-
ment; and 0.8–1.0, excellent agreement.22 The signiﬁcance level
used for the analyses was 5% (p < 0.05).
3. Results
Out of the 1265 patients included in the study, 933 (73.8%)
presented a clinical suspicion of paucibacillary leprosy and 332
(26.2%) of multibacillary leprosy. From direct smear microscopy
performed on the lesion, 67 (7.2%) of those classiﬁed as pauciba-
cillary cases were positive and were reclassiﬁed as multibacillary,
and 125 (37.7%) initially suspected of being multibacillary cases
were negative and were reclassiﬁed as paucibacillary.
Meanwhile, among those initially classiﬁed as paucibacillary
cases, 866 (92.8%) were negative on smear microscopy, and 207
(62.3%) initially classiﬁed as multibacillary patients were positive
on smear microscopy. The overall agreement between the initial
and ﬁnal operational classiﬁcations was 84.8% (1073/1265), which
was considered moderate (kappa = 0.584, p = 0.000) (Table 1).
Table 2 shows the evaluation of the concordance between the
clinical classiﬁcation (diagnostic suspicion) and histopathological
classiﬁcation of the 1265 patients. The data analysis showed an
overall agreement of 58.1% (735/1265), which was considered
weak (kappa = 0.371, p = 0.000). The indeterminate and leproma-
tous forms were those with the highest percentage agreements:
72.1% (186/258) and 71% (142/200), respectively. The tuberculoid
form presented agreement of 58.0% (375/646) and the intermedi-
ate forms (dimorphic) presented the lowest agreement, of 19.9%
(32/161).
On the other hand, the histopathological examinations of skin
biopsies in 41.9% (530/1265) of the patients showed changes to theicroscopy on the lesion; PDNPM, 1985–2005
(direct smear Agreement, n (%) Total
Multibacillary
67 866/933 (92.8%) 933
207 207/332 (62.3%) 332
274 1073/1265 (84.8%) 1265
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one pole of the spectrum to the other.
4. Discussion
The correct classiﬁcation of leprosy cases is an important tool
for the proper allocation of patients in the multidrug therapy
(MDT) program, since the duration of treatment and dosage of
medication used differ between the paucibacillary and multi-
bacillary forms.14Accordingly, evaluation of the agreement be-
tween classiﬁcation systems using clinical criteria and those based
on laboratory tests have been a frequent focus of studies over the
last few years,6 especially since the publication of the WHO
operational classiﬁcation, which recommends that the sole
criterion for classifying patients should be the number of skin
lesions, with allocation into two different therapeutic regimens.14
Studies have shown that the use of this classiﬁcation method alone,
in routine practice within healthcare services, presents limitations
and different percentages of sensitivity and speciﬁcity.5,6,23–25
In the present study, the general agreement between the initial
and ﬁnal operational classiﬁcations was 84.8%. Other studies have
shown concordance ranging from 83.1% to 89.3%.5,8,25 The lowest
agreement was among multibacillary patients, which shows the
need to conduct smear microscopy, in order to increase the rate of
diagnosis.
It was found that smear microscopy on the lesion changed the
classiﬁcation in approximately 15% of the cases. Teixeira et al.8
evaluated the agreement between the WHO operational classiﬁca-
tion and the smear microscopy index for lymph and demonstrated
that smear microscopy changed the diagnosis in 5% of the cases. This
lack of agreement between the data of the present study and the data
of Teixeira et al.8 can be explained by the fact that direct smear
microscopy on the lesion makes it possible to ﬁnd bacilli in the deep
reticular dermis, where bacilli remain inaccessible to lymph smear
microscopy.26 Bhushan et al.20 evaluated the agreement between
lymph and slit-skin smear microscopy, and found that the smear
microscopy of the lesion identiﬁed more multibacillary patients.
These authors concluded that smear microscopy of the lesion has a
greater sensitivity and speciﬁcity and should be done routinely,
when available, for classifying patients.
The results from the present study showed that 67 (7.2%) of the
paucibacillary cases were reclassiﬁed as multibacillary. This error
in classifying patients may represent a situation of inadequate
treatment that consequently increases the risk of recurrence and
the period for which the patient would continue to be a source of
infection, due to under-treatment. On the other hand, 125 patients
(37.7%) who were initially classiﬁed as multibacillary were
negative on smear microscopy, thus indicating that they would
be unnecessarily subjected to treatments that could potentially
result in serious adverse effects and increase the spending on
healthcare services.5
The agreement between the clinical suspicion according to the
Madrid classiﬁcation and the histopathology of the lesion was
58.1%. Other authors have reported percentage agreements
ranging from 29.7% to 89.0%.8,17–20,27–32 The greatest agreements
have occurred with the polar forms and the smallest rates with the
intermediate forms (dimorphic).8,20,21
It was found that the histopathological analysis signiﬁcantly
changed the classiﬁcation of the patients in 20.2% (256/1265) of
the cases, i.e. they moved from one pole of the spectrum to the
other. This was because patients histopathologically classiﬁed as I,
TT, and BT were treated as paucibacillary, and those diagnosed as
BB, BL, and LL received the therapeutic regimen for multi-
bacillary.14 Therefore, the importance of complementary labora-
tory tests to help in diagnosing and correctly classifying leprosy is
emphasized.21Because of the wide spectrum of clinical manifestations of
leprosy, studies have shown the importance of using histopatho-
logical criteria among patients with leprosy, and correlating results
with the clinical diagnosis, in order to improve the classiﬁcation of
the patients, as well as the prognosis and treatment.8,20,21,33,34
In conclusion, the analysis in this study showed moderate
agreement between the operational classiﬁcation based on the
WHO and operational classiﬁcation based on smear, and weak
agreement between the Madrid classiﬁcation and pathology. The
ﬁndings suggest that for a correct classiﬁcation of the forms of
leprosy and thus for the institution of appropriate therapy,
histological examinations of the lesion should be performed,
associated with clinical signs of the disease.
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